| - Industry | - Sector | Mr. Nick England CEO | CNSX Exchange | CA24381B1040 ISIN |
| Australia Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
PharmX Technologies Limited, headquartered in Sydney, Australia, operates as a leading technology and software development company with a strong foothold in the Australian market. Initially trading under the name Corum Group Limited, the company underwent a significant rebranding in October 2023 to better reflect its innovative approach and the essence of its core business offerings. Established in 1950, PharmX Technologies Limited has evolved over the years, diversifying its portfolio to meet the dynamic needs of the healthcare industry. Together with its subsidiaries, the company specializes in delivering high-quality digital solutions aimed at enhancing the efficiency and effectiveness of pharmacy operations and supplier engagements.
An electronic ordering gateway that streamlines the process of purchasing and supply chain management for pharmacies and suppliers. This platform facilitates efficient and secure transactions, ensuring real-time communication between pharmacies and their suppliers, thereby optimizing inventory management and reducing operational costs.
An innovative online sales and marketing platform designed to bridge the gap between pharmacies and product suppliers. The marketplace enables pharmacies to access a wide range of products and services, offering competitive pricing and promotional opportunities. This platform serves as a digital conduit, fostering greater visibility for suppliers while providing pharmacies with the tools necessary to enhance their sales and customer engagement strategies.
A comprehensive analytics service that delivers actionable insights tailored to the operations of both supplier and pharmacy customers. By leveraging data analytics, PharmX Technologies Limited empowers its clients with the ability to make informed decisions, improve operational efficiency, and drive strategic growth. This service encompasses a range of analytical tools and reporting mechanisms designed to uncover trends, performance metrics, and areas for improvement within the pharmaceutical supply chain.